These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

361 related items for PubMed ID: 15854190

  • 1. Short-acting beta 2-agonist and oral corticosteroid use in asthma patients prescribed either concurrent beclomethasone and long-acting beta 2-agonist or salmeterol/fluticasone propionate combination.
    Angus R, Reagon R, Cheesbrough A.
    Int J Clin Pract; 2005 Feb; 59(2):156-62. PubMed ID: 15854190
    [Abstract] [Full Text] [Related]

  • 2. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study.
    Cowie RL, Boulet LP, Keith PK, Scott-Wilson CA, House KW, Dorinsky PM.
    Clin Ther; 2007 Jul; 29(7):1390-402. PubMed ID: 17825690
    [Abstract] [Full Text] [Related]

  • 3. [Influence of changing inhalation device from separate diskus of salmeterol and fluticasone propionate to combination diskus in asthma patients].
    Miyagawa T.
    Arerugi; 2008 Nov; 57(11):1134-44. PubMed ID: 19052508
    [Abstract] [Full Text] [Related]

  • 4. Association between previous health care use and initiation of inhaled corticosteroid and long-acting beta2-adrenergic agonist combination therapy among US patients with asthma.
    Blanchette CM, Culler SD, Ershoff D, Gutierrez B.
    Clin Ther; 2009 Nov; 31(11):2574-83. PubMed ID: 20110003
    [Abstract] [Full Text] [Related]

  • 5. Combination inhalers containing inhaled corticosteroids and long-acting beta2-agonists: improved clinical efficacy and dosing options in patients with asthma.
    Ankerst J.
    J Asthma; 2005 Nov; 42(9):715-24. PubMed ID: 16316864
    [Abstract] [Full Text] [Related]

  • 6. Survival among COPD patients using fluticasone/salmeterol in combination versus other inhaled steroids and bronchodilators alone.
    Mapel DW, Nelson LS, Lydick E, Soriano J, Yood MU, Davis KJ.
    COPD; 2007 Jun; 4(2):127-34. PubMed ID: 17530506
    [Abstract] [Full Text] [Related]

  • 7. Randomized controlled trial of adherence with single or combination inhaled corticosteroid/long-acting beta-agonist inhaler therapy in asthma.
    Perrin K, Williams M, Wijesinghe M, James K, Weatherall M, Beasley R.
    J Allergy Clin Immunol; 2010 Sep; 126(3):505-10. PubMed ID: 20816187
    [Abstract] [Full Text] [Related]

  • 8. [A fixed combination of fluticasone and salmeterol permits better control of asthma than a beclomethasone dipropionate and montelukast combination].
    Grosclaude M, Cerruti JL, Delannay B, Hérent M, Spilthooren F, Desfougères JL.
    Eur Ann Allergy Clin Immunol; 2003 Nov; 35(9):356-62. PubMed ID: 14716965
    [Abstract] [Full Text] [Related]

  • 9. Inhaled corticosteroid and long-acting β2-agonist pharmacological profiles: effective asthma therapy in practice.
    Tamm M, Richards DH, Beghé B, Fabbri L.
    Respir Med; 2012 Dec; 106 Suppl 1():S9-19. PubMed ID: 23273165
    [Abstract] [Full Text] [Related]

  • 10. [Budesonide/formoterol maintenance and reliever therapy. A new treatment approach for adult patients with asthma].
    Korn S, Vogelmeier C, Buhl R.
    Med Klin (Munich); 2008 May 15; 103(5):299-310. PubMed ID: 18484216
    [Abstract] [Full Text] [Related]

  • 11. Appropriate use of inhaled corticosteroid and long-acting beta(2)-adrenergic agonist combination therapy among asthma patients in a US commercially insured population.
    Ye X, Gutierrez B, Zarotsky V, Nelson M, Blanchette CM.
    Curr Med Res Opin; 2009 Sep 15; 25(9):2251-8. PubMed ID: 19622006
    [Abstract] [Full Text] [Related]

  • 12. Adding long-acting beta-agonists to inhaled corticosteroids after discharge from the emergency department for acute asthma: a randomized controlled trial.
    Rowe BH, Wong E, Blitz S, Diner B, Mackey D, Ross S, Senthilselvan A.
    Acad Emerg Med; 2007 Oct 15; 14(10):833-40. PubMed ID: 17898245
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: A prospective, randomized, double-blind, double-dummy, parallel-group study.
    Maspero J, Guerra F, Cuevas F, Gutierrez JP, Soto-Ramos M, Anderton S, Mechali D, Chan R, Pedersen S.
    Clin Ther; 2008 Aug 15; 30(8):1492-504. PubMed ID: 18803991
    [Abstract] [Full Text] [Related]

  • 14. Cost-effectiveness of salmeterol xinafoate/fluticasone propionate combination inhaler in chronic asthma.
    Doull I, Price D, Thomas M, Hawkins N, Stamuli E, Tabberer M, Gosden T, Rudge H.
    Curr Med Res Opin; 2007 May 15; 23(5):1147-59. PubMed ID: 17519082
    [Abstract] [Full Text] [Related]

  • 15. A retrospective database study comparing treatment outcomes and cost associated with choice of fixed-dose inhaled corticosteroid/long-acting beta-agonists for asthma maintenance treatment in Germany.
    Aballéa S, Cure S, Vogelmeier C, Wirén A.
    Int J Clin Pract; 2008 Dec 15; 62(12):1870-9. PubMed ID: 18803555
    [Abstract] [Full Text] [Related]

  • 16. Effects of fluticasone propionate/salmeterol combination on asthma-related health care resource utilization and costs and adherence in children and adults with asthma.
    Delea TE, Hagiwara M, Stanford RH, Stempel DA.
    Clin Ther; 2008 Mar 15; 30(3):560-71. PubMed ID: 18405796
    [Abstract] [Full Text] [Related]

  • 17. Salmeterol response is not affected by beta2-adrenergic receptor genotype in subjects with persistent asthma.
    Bleecker ER, Yancey SW, Baitinger LA, Edwards LD, Klotsman M, Anderson WH, Dorinsky PM.
    J Allergy Clin Immunol; 2006 Oct 15; 118(4):809-16. PubMed ID: 17030231
    [Abstract] [Full Text] [Related]

  • 18. Resource utilization with fluticasone propionate and salmeterol in a single inhaler compared with other controller therapies in children with asthma.
    Stempel DA, Riedel AA, Carranza Rosenzweig JR.
    Curr Med Res Opin; 2006 Mar 15; 22(3):463-70. PubMed ID: 16574030
    [Abstract] [Full Text] [Related]

  • 19. [Combination treatment with inhaled corticosteroid/long-acting beta 2-adrenergic bronchodilator in the treatment of asthma].
    Kimura T, Adachi M.
    Nihon Rinsho; 2001 Oct 15; 59(10):1992-9. PubMed ID: 11676144
    [Abstract] [Full Text] [Related]

  • 20. Effects on resource utilization of adding salmeterol in combination or separately to inhaled corticosteroids.
    Chan J, Hui RL, Spence MM.
    J Manag Care Pharm; 2007 Oct 15; 13(1):21-7. PubMed ID: 17269833
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.